Announce Date | 04/30/2025 |
EPS Normalized Actual | $1.66 (Miss by $-0.01) |
EPS GAAP Actual | $1.66 (Miss by $-0.01) |
Revenue Actual | $3.398B |
Revenue Surprise | Beat by $3398M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 8.2519 | 12.33 | 7.94934 | 8.56269 | 1 |
Dec 2027 | 7.3984 | 13.76 | 7.0023 | 7.85676 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.05 | 0.05 | 3.398B | -59.98% | 3398M |
FQ4 2024 (Dec 2024) | 3.41 | 3.41 | 5.498B | 31.3% | 5498M |
FQ3 2024 (Sep 2024) | -0.17 | -0.17 | 2.949B | -67.85% | 2949M |
FQ2 2024 (Jun 2024) | 3.11 | 3.11 | 5.138B | -0.66% | 5138M |
FQ1 2024 (Mar 2024) | 3.27 | 3.27 | 5.436B | 11.7% | 5436M |
FQ4 2023 (Dec 2023) | 0.46 | 0.46 | 3.777B | -6.17% | 3777M |
FQ3 2023 (Sep 2023) | 2.65 | 2.65 | 4.95B | 2.63% | 4950M |
FQ2 2023 (Jun 2023) | 2.72 | 2.72 | 5.172B | -4.41% | 5172M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2028 (Sep 2028) | 2.0866 | -- | 2.00453 | 2.13365 | 5 |
FQ2 2028 (Jun 2028) | 2.0918 | -- | 2.00952 | 2.13897 | 5 |
FQ1 2028 (Mar 2028) | 2.1026 | -- | 2.0199 | 2.15001 | 5 |
FQ4 2027 (Oct 2027) | 1.8546 | -- | 1.8546 | 1.8546 | 4 |
FQ3 2027 (Jul 2027) | 1.8655 | -- | 1.8655 | 1.8655 | 3 |
FQ2 2027 (Jun 2027) | 1.8655 | -- | 1.75953 | 2.03713 | 3 |
FQ1 2027 (Mar 2027) | 1.875 | -- | 1.76849 | 2.0475 | 6 |
FQ4 2026 (Oct 2026) | 1.88 | -- | 1.76139 | 2.02386 | 3 |
FQ3 2026 (Jul 2026) | 1.84 | -- | 1.72392 | 1.9808 | 5 |
FQ2 2026 (Jun 2026) | 1.86 | -- | 1.66903 | 1.9544 | 5 |
FQ1 2026 (Mar 2026) | 1.83 | 97.27 | 1.64211 | 1.92287 | 3 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2028 (Sep 2028) | 4.72B | -- | 4.58B | 4.8B | 1 |
FQ2 2028 (Jun 2028) | 4.7B | -- | 4.55B | 4.78B | 1 |
FQ1 2028 (Mar 2028) | 4.7B | -- | 4.55B | 4.78B | 1 |
FQ4 2027 (Oct 2027) | 4.4B | -- | 4.4B | 4.4B | 2 |
FQ3 2027 (Jul 2027) | 4.39B | -- | 4.39B | 4.39B | 2 |
FQ2 2027 (Jun 2027) | 4.39B | -- | 4.2B | 4.7B | 4 |
FQ1 2027 (Mar 2027) | 4.4B | -- | 4.21B | 4.71B | 4 |
FQ4 2026 (Oct 2026) | 3.6B | -- | 3.42B | 3.81B | 2 |
FQ3 2026 (Jul 2026) | 3.6B | -- | 3.42B | 3.81B | 2 |
FQ2 2026 (Jun 2026) | 3.6B | -- | 3.31B | 3.74B | 2 |
FQ1 2026 (Mar 2026) | 3.59B | 5.45 | 3.31B | 3.73B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.05 | 0.05 | 100% | |
FQ4 2024 (Dec 2024) | 3.41 | 3.41 | 100% | |
FQ3 2024 (Sep 2024) | -0.17 | -0.17 | 100% | |
FQ2 2024 (Jun 2024) | 3.11 | 3.11 | 100% | |
FQ1 2024 (Mar 2024) | 3.27 | 3.27 | 100% | |
FQ4 2023 (Dec 2023) | 0.46 | 0.46 | 100% | |
FQ3 2023 (Sep 2023) | 2.65 | 2.65 | 100% | |
FQ2 2023 (Jun 2023) | 2.72 | 2.72 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $3.4B | $3398M | 100% |
FQ4 2024 (Dec 2024) | $0B | $5.5B | $5498M | 100% |
FQ3 2024 (Sep 2024) | $0B | $2.95B | $2949M | 100% |
FQ2 2024 (Jun 2024) | $0B | $5.14B | $5138M | 100% |
FQ1 2024 (Mar 2024) | $0B | $5.44B | $5436M | 100% |
FQ4 2023 (Dec 2023) | $0B | $3.78B | $3777M | 100% |
FQ3 2023 (Sep 2023) | $0B | $4.95B | $4950M | 100% |
FQ2 2023 (Jun 2023) | $0B | $5.17B | $5172M | 100% |